1443670-63-0

Basic information

• Product Name: N-[1-(4-hydroxy-3-fluoro-phenyl)-ethyl]-acetamide
• Synonyms: N-[1-(4-hydroxy-3-fluoro-phenyl)-ethyl]-acetamide
• CAS NO: 1443670-63-0
• Molecular Weight: 197.209
• Mol File: 1443670-63-0.mol

Chemical Properties

• CAS DataBase Reference: N-[1-(4-hydroxy-3-fluoro-phenyl)-ethyl]-acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[1-(4-hydroxy-3-fluoro-phenyl)-ethyl]-acetamide(1443670-63-0)
• EPA Substance Registry System: N-[1-(4-hydroxy-3-fluoro-phenyl)-ethyl]-acetamide(1443670-63-0)

Safety Data

• Hazardous Substances Data: 1443670-63-0(Hazardous Substances Data)

Upstream product

• 1444780-23-7 2-methyl-propane-2-sulfonic acid 4-bromo-3-fluoro-benzylideneamide 
• 1443670-60-7 N-[1-(4-bromo-3-fluoro-phenyl)-ethyl]-acetamide 
• 1270343-17-3 C₈H₉BrFN 
• 1444780-35-1 2-methyl-propane-2-sulfonic acid [1-(4-bromo-3-fluoro-phenyl)-ethyl]-amide 
• 133059-43-5 4-bromo-3-fluorobenzaldehyde 

Downstream Products

• 1443670-27-6 N-(1-(4-(1-(4-(cyclopropylmethoxy)phenyl)azetidin-3-yloxy)-3-fluorophenyl)ethyl)-acetamide 

Relevant articles and documents

New pyrrolidine derivatives, pharmaceutical compositions and uses thereof

Pyrrolidine derivatives of the formula and their use as medicaments for the treatment of obesity and type 2 diabetes.

NEW PYRROLIDINE DERIVATIVES AND THEIR USE AS ACETYL-COA CARBOXYLASE INHIBITORS

The invention relates to new pyrrolidine derivatives of the formula (I) to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.

AZETIDINE DERIVATIVES

Azetidine derivatives of which the following is exemplary and their use in the treatment of obesity, diabetes or dyslipidemia.

NEW AZIRIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS ACETYL-COA CARBOXYLASE INHIBITORS

The invention relates to new azetidine derivatives of the formula (I) wherein Ar1, Ar2, X, R, T and L are as defined in the description, to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.